Oric Pharmaceuticals
- Market cap
- 1.24B
- P/E (TTM)i
- -9.24
- P/Bi
- 3.27
- EPSi
- -1.47
- Div yieldi
- 0.00%
- 52W posi
- 64%
Anonymous reader poll. Unscientific, not investment advice.
Oric Pharmaceuticals shares were changing hands at 12.01, up 0.25% on the day. That leaves the company valued at approximately 1.24B, the #3089 most valuable US-listed company we track. The 9 analysts covering the stock are, on balance, at Buy, targeting an average of 22.78 (+90%). Against a 52-week band of 7.23-14.68, the shares are currently 64% of the way up.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 1 day.
- Its last 8 Sell calls were actually followed by a +21% average gain three months out - this one has bounced back faster than the signal expected.
- Recent price momentum is -2.3% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 16.9% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 11.98
- Open
- 11.83
- Day range
- 11.81 - 12.43
- Avg price
- 12.11
- Volume
- 790.78K
- Turnover
- 9.58M
- Turnover ratei
- 0.89%
- Volume ratioi
- 0.47
- Amplitudei
- 5.18%
- 52-week rangei
- 7.23 - 14.68
Valuation
- P/Ei
- -8.17
- P/E (TTM)i
- -9.24
- P/Bi
- 3.27
- EPSi
- -1.47
- Book value / shi
- 3.68
- Net profit
- -152.37M
- Net assets
- 381.23M
Share structure
- Market cap
- 1.24B
- Float capi
- 1.07B
- Shares out
- 103.65M
- Float sharesi
- 88.69M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2020-04-24
18.2% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-6.44M net over the window
Short interest
- Shares short
- 17.53M
- % of floati
- 16.91%
- Days to coveri
- 14.21
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Oric Pharmaceuticals (ORIC)?
Oric Pharmaceuticals last traded at 12.01. The quote on this page refreshes every few seconds while US markets are open.
What is Oric Pharmaceuticals's market cap?
About 1.24B.
What is the P/E ratio of Oric Pharmaceuticals?
The trailing twelve-month P/E is -9.24. The Valuation tab shows it against the stock's own five-year range.
Does Oric Pharmaceuticals pay a dividend?
Oric Pharmaceuticals does not currently pay a regular dividend.
Is Oric Pharmaceuticals a buy according to analysts?
The consensus of 9 analysts is a Buy rating, with an average 12-month price target of 22.78, which implies 89.7% upside from the current price. This is not investment advice.
What is Oric Pharmaceuticals's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Oric Pharmaceuticals a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-08 07:33:13 · For reference only, not investment advice and not tailored to your situation.